• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有下腔静脉侵犯和/或血栓形成的肝细胞癌手术切除的治疗结果

Treatment outcomes of surgical resection for hepatocellular carcinoma with inferior vena cava invasion and/or thrombosis.

作者信息

Jung Hyemin, Lee Kuhn Uk, Shin Woo Young, Ahn Hyuk

机构信息

Department of Surgery, Seoul National University Hospital, Seoul, Korea.

出版信息

Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1694-9. doi: 10.5754/hge10653. Epub 2011 Jul 15.

DOI:10.5754/hge10653
PMID:21940334
Abstract

BACKGROUND/AIMS: Advanced hepatocellular carcinoma with either an invasion of the inferior vena cava or thrombosis is rare, and its prognosis is extremely poor. There is no established treatment. The purpose of this study was to evaluate the efficacy of surgical resection and its prognosis in 5 recent cases.

METHODOLOGY

From January 2005 to December 2008, 5 patients diagnosed with advanced hepatocellular carcinoma with inferior vena cava invasion and/or thrombosis underwent surgical resection. These patients were retrospectively reviewed.

RESULTS

The mean age at diagnosis was 54 years. There were 4 men and 1 woman. According to the Child-Pugh classification, all patients were class A. One case had 2 hepatic masses, and the others had a solitary hepatic mass. The mean tumor size was 5.53cm. All 5 patients underwent partial hepatectomy and inferior vena cava resection or thrombosis removal. Among these, 4 cases needed a cardiopulmonary bypass. Four patients survived and 1 patient expired at the point of analyzing. Four cases experienced recurrences. The mean disease-free survival time was 19.6 months. One patient has been followed-up for 43 months without any recurrences up to now.

CONCLUSIONS

Concurrent en-bloc resection of the liver and inferior vena cava for progressive HCC accompanying IVC invasion or thrombosis can be considered as a curative treatment.

摘要

背景/目的:侵犯下腔静脉或伴有血栓形成的晚期肝细胞癌较为罕见,其预后极差。目前尚无成熟的治疗方法。本研究旨在评估近期5例此类患者手术切除的疗效及其预后。

方法

2005年1月至2008年12月,5例诊断为侵犯下腔静脉和/或伴有血栓形成的晚期肝细胞癌患者接受了手术切除。对这些患者进行回顾性分析。

结果

确诊时的平均年龄为54岁。男性4例,女性1例。根据Child-Pugh分级,所有患者均为A级。1例有2个肝肿块,其余患者有单个肝肿块。平均肿瘤大小为5.53cm。所有5例患者均接受了肝部分切除术及下腔静脉切除术或血栓清除术。其中4例需要体外循环。在分析时,4例患者存活,1例患者死亡。4例出现复发。平均无病生存期为19.6个月。1例患者随访43个月,至今无任何复发。

结论

对于伴有下腔静脉侵犯或血栓形成的进展期肝癌,同期整块切除肝脏和下腔静脉可被视为一种根治性治疗方法。

相似文献

1
Treatment outcomes of surgical resection for hepatocellular carcinoma with inferior vena cava invasion and/or thrombosis.伴有下腔静脉侵犯和/或血栓形成的肝细胞癌手术切除的治疗结果
Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1694-9. doi: 10.5754/hge10653. Epub 2011 Jul 15.
2
Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.在伴有腔静脉和肝脏侵犯的晚期肾上腺恶性肿瘤肝切除术中,采用不同寻常的技术来保证手术和肿瘤学安全性。
Ann Surg Oncol. 2018 Oct;25(11):3324-3325. doi: 10.1245/s10434-018-6657-5. Epub 2018 Jul 17.
3
Significance of hepatic resection combined with inferior vena cava resection and its reconstruction with expanded polytetrafluoroethylene for treatment of liver tumors.肝切除联合下腔静脉切除及用膨体聚四氟乙烯重建下腔静脉治疗肝肿瘤的意义
J Am Coll Surg. 2003 Feb;196(2):243-9. doi: 10.1016/S1072-7515(02)01616-2.
4
Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein.比较肝切除术和血栓切除术在伴有下腔静脉和肝静脉肿瘤血栓的肝细胞癌患者中使用全肝血管阻断和单纯化疗的生存和生活质量。
Eur J Gastroenterol Hepatol. 2012 Feb;24(2):186-94. doi: 10.1097/MEG.0b013e32834dda64.
5
Is combined partial hepatectomy with segmental resection of inferior vena cava justified for malignancy?联合部分肝切除术与下腔静脉节段性切除术治疗恶性肿瘤是否合理?
Arch Surg. 2003 Jun;138(6):624-30; discussion 630-1. doi: 10.1001/archsurg.138.6.624.
6
Recurrent hepatocellular carcinoma with tumor thrombus in right atrium - report of a successful liver resection with tumor thrombectomy using total hepatic vascular exclusion without concomitant cardiopulmonary bypass.右心房有瘤栓的复发性肝细胞癌——关于在不进行体外循环的情况下采用全肝血管阻断行肝切除及肿瘤血栓切除术并获成功的报告
Hepatogastroenterology. 2012 May;59(115):872-4. doi: 10.5754/hge10662.
7
Aggressive surgical resection for hepatocellular carcinoma with tumor thrombus extending to inferior vena cava and synchronous pulmonary metastasis.对肿瘤血栓延伸至下腔静脉并伴有同步肺转移的肝细胞癌进行积极手术切除。
Hepatogastroenterology. 2004 Sep-Oct;51(59):1326-9.
8
Hepatic resection through an anterior approach employing a modified liver hanging maneuver in patients with a massive liver tumor severely oppressing the inferior vena cava.对于巨大肝肿瘤严重压迫下腔静脉的患者,采用改良肝脏悬吊手法经前路进行肝切除术。
Hepatogastroenterology. 2004 Sep-Oct;51(59):1459-63.
9
Resection of the inferior vena cava for hepatic malignancy.为治疗肝脏恶性肿瘤而切除下腔静脉。
Am Surg. 2001 Nov;67(11):1081-7; discussion 1087-8.
10
Surgery for hepatocellular carcinoma with tumor thrombus extending into the right atrium: report of a successful resection without the use of cardiopulmonary bypass.肝细胞癌合并肿瘤血栓延伸至右心房的手术治疗:一例未使用体外循环成功切除的病例报告
Hepatogastroenterology. 2004 Sep-Oct;51(59):1259-62.

引用本文的文献

1
Robot Assisted Laparoscopy Combined with Thoracoscopy in the Treatment of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus.机器人辅助腹腔镜联合胸腔镜治疗肝癌合并下腔静脉癌栓。
Ann Surg Oncol. 2023 Sep;30(9):5447-5449. doi: 10.1245/s10434-023-13512-5. Epub 2023 Jun 7.
2
Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy.血管切除与重建在肝脏恶性肿瘤手术中的作用演变
Hepat Oncol. 2014 Jan;1(1):53-65. doi: 10.2217/hep.13.5. Epub 2013 Dec 20.
3
Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium.
伴有下腔静脉或右心房癌栓的肝细胞癌手术治疗结果
Surg Today. 2018 Sep;48(9):819-824. doi: 10.1007/s00595-017-1619-2. Epub 2017 Dec 26.
4
Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis.伴有门静脉癌栓的肝细胞癌的多模态治疗:一项大规模、多中心、倾向评分分析
Medicine (Baltimore). 2016 Mar;95(11):e3015. doi: 10.1097/MD.0000000000003015.
5
Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.索拉非尼联合肝切除术后下腔静脉肿瘤血栓形成的肝细胞癌患者的无复发生存期
Int Surg. 2015 May;100(5):908-14. doi: 10.9738/INTSURG-D-14-00133.1.
6
Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review.索拉非尼联合经动脉化疗栓塞治疗伴有下腔静脉瘤栓的肝细胞癌患者的长期生存:2例报告及文献复习
Chin J Cancer. 2014 May;33(5):259-64. doi: 10.5732/cjc.013.10133. Epub 2013 Dec 11.
7
Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium.肝细胞癌伴下腔静脉或右心房癌栓的外科治疗。
World J Surg Oncol. 2013 Oct 5;11:259. doi: 10.1186/1477-7819-11-259.
8
Liver resection with concomitant inferior vena cava resection: experiences without veno-venous bypass.肝切除联合下腔静脉切除:无静脉转流的经验
Surg Today. 2014 Jun;44(6):1063-71. doi: 10.1007/s00595-013-0652-z. Epub 2013 Jun 26.